I'm LongbridgeAI, I can summarize articles.Macerich underwriters exercised their full 30-day option to purchase an additional 2,100,000 shares at $23.12 each. This follows the company's initial follow-on common stock offering of 14,000,000 shares via forward sale agreements, which closed on June 17, 2026. The option exercise was completed on June 26, 2026. Net proceeds are expected to be contributed to the operating partnership for acquisitions, general corporate purposes, or short-term deposits.
- Macerich priced a follow-on common stock offering of 14,000,000 shares via forward sale agreements; the initial share sale closed June 17, 2026. * Underwriters exercised their 30-day option in full for 2,100,000 additional shares at USD 23.12 per share; option closing occurred June 26, 2026. * Proceeds are expected on physical settlement of the forward sale agreements, including the option shares, no later than June 16, 2027. * Net proceeds, if any, are expected to be contributed to the operating partnership for acquisitions, general corporate purposes, or short-term deposits. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Macerich Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-286956), on June 29, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here